Capital Impact Advisors »

ACADIA Pharmaceuticals shares owned by Capital Impact Advisors

Quarter-by-quarter ownership of ACADIA Pharmaceuticals (ACAD) shares owned by Capital Impact Advisors from 13F filings

Historical chart of Capital Impact Advisors investment in ACADIA Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including ACADIA Pharmaceuticals held by Capital Impact Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ACADIA Pharmaceuticals by Capital Impact Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $303k 9.7k 31.31
2023-09-30 $202k 9.7k 20.84
2023-06-30 $464k 19k 23.95
2023-03-31 $365k 19k 18.82
2022-12-31 $290k 18k 15.92
2022-09-30 $315k 21k 14.96
2022-06-30 $459k 33k 14.08
2022-03-31 $701k 29k 24.21
2021-12-31 $515k 22k 23.33